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We investigated the eﬀects of ultraviolet A1 (UVA1) irradiation on spontaneous lupus erythematosus- (LE-) like skin lesions
of MRL/lpr mice, using a disease prevention model. UVA1 irradiation signiﬁcantly inhibited the development of LE-like skin
lesions, without obvious changes of the disease including renal disease and serum antinuclear antibody levels. Besides the massive
inﬁltration of mast cells in the LE-like skin lesions, in the nonlesional skins, more mast cells inﬁltrated in the UVA1-irradiated
group compared with the nonirradiated group. Although apoptotic cells were remarkably seen in the dermis of UVA1-irradiated
mice, those cells were hardly detectable in the dermis of the nonirradiated mice without skin lesions. Further analysis showed
that some of those apoptotic cells were mast cells. Thus, UVA1 might exert its eﬀects, at least in part, through the induction of the
apoptosisof pathogenic mast cells.Our resultssupportedtheclinical eﬃcacy of UVA1 irradiationfor skinlesions of lupuspatients.
Copyright © 2009 Naoya Mikita et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Collagen disease, one of the representative autoimmune
diseases, is often accompanied by photosensitivity. In partic-
ular, photosensitivity is included in its diagnostic criteria of
systemic lupus erythematosus (SLE) [1, 2], and it has been
reported that, in Japan, about 60% of SLE patients showed
photosensitivity [3, 4]. In addition, exposure to sunlight is a
well-known risk factor that induces or exacerbates not only
skin lesions but also systemic symptoms for SLE patients. To
investigate the eﬀects of sunlight on SLE, some studies using
MRL/lprmice,oneofthemajorlupus-pronemice,havebeen
performed. MRL/lpr mice are characterized by dysregulated
apoptosis due to defective signaling through Fas antigen
[5] and by autoimmune symptoms including fetal nephritis,
autoantibody production, and lymphoadenopathy. Further-
more, some of MRL/lpr mice spontaneously develop LE-
like skin lesions with alopecia and scab formation on their
upper back region [6–8]. In cultured cells from MRL/lpr
mice, the cytotoxicity of ultraviolet (UV) irradiation was
signiﬁcantly elevated [9]. In line with this, UVB exposure
signiﬁcantly exaggerated the development of LE-like skin
lesions in MRL/lpr mice [10]. Moreover, UVA could also
exacerbate the skin lesions in SLE patients [11]. On the
contrary, several recent studies demonstrated that UVA1
irradiation had therapeutic eﬀects for SLE patients [12–15].
Ultraviolet can be divided into three diﬀerent parts based
on the wavelength as follows: UVA (320–400nm), UVB
(290–320nm), and UVC (200–290nm). Moreover, UVA is
made up of two parts: UVA1 (340–400nm) and UVA2
(320–340nm). UVC is absorbed by the ozone layer and
does not reach the ground, whereas UVA and UVB have
diﬀerent various biological eﬀects. For example, UVA and
UVB induce suntan without an erythema response and
suntan with sunburn, respectively [16, 17]. Although the
biological eﬀects of UVA2 are similar to the eﬀects of UVB,
only UVA1 possesses the particular characteristic biological
functions. In the previous studies with MRL/lpr mice [9, 10],
the biological eﬀects of UVB but not UVA1 were mainly
investigated. McGrath Jr. et al. reported the systemic eﬀects
of UVA, not UVA1, on other SLE model mice (NeaZealand
black × NeaZealand white), F1 hybrid mice harboring no2 Clinical and Developmental Immunology
skin lesions [18]. However, to the best of our knowledge,
there have been no studies examining the UVA1 eﬀects on
theLE-likeskinlesionsofSLEmodelmice,andthebiological
eﬀects of UVA1 on SLE still remain investigated. In the
present study, we investigated the eﬀects of UVA1 irradiation
on MRL/lpr mice, particularly on their LE-like skin lesions,
using a disease prevention model. Simultaneously, we also
studied the dermal inﬁltration of mast cells, histamine
receptor (HR) expression [19] and the mRNA expression
of cytokines [20], which were previously examined in the
spontaneous LE-like skin lesions in MRL/lpr mice [19, 20].
2.MaterialsandMethods
2.1. Antibodies (Abs). In the present study, the following
Abs were used: rabbit antimouse histamine 1 receptor
(H1R) polyclonal Ab (pAb), goat antimouse H2R pAb, goat
antimouse H3R pAb (Santa Cruz Biotechnology, Inc., Santa
Cruz, Calif, USA), and rat antimouse IL-10 monoclonal Ab
(mAb) (BD Biosciences, San Jose, Calif, USA).
2.2. Mice. MRL/lpr mice, aged 4–6 weeks at the start of
each experiment, were purchased from Japan SLC Inc.
(Hamamatsu, Japan) and housed individually in cages under
thespeciﬁcpathogenfreeconditions.Allanimalexperiments
were approved by the Committee on Animal Care and Use at
Wakayama Medical University.
2.3. UVA1 Sources and Irradiation of Mice. The UVA1
source was a TLK/40W/10R/UVA PHILIPS lamp (PHILIPS,
Amsterdam, The Netherlands). This lamp emitted long wave
UV light ranging from 350–400nm (within the UVA1 range
(320–400nm)) with a peak at 365nm. The UVA1 irradiation
equipment consisted of four of these lamps (Yayoi Co., Ltd.,
Tokyo, Japan).
The MRL/lpr mice were divided into the following three
groups: (1) nonirradiation group (n = 22), (2) UVA1
irradiation with 5J/cm2 (n = 18), and (3) UVA1 irradiation
with 10J/cm2 (n = 18). The doses of 5 and 10J/cm2 have
been chosen by the following reasons: ﬁrst, eﬀective doses
of UVA1 treatment for human SLE patients were reportedly
low, such as 6 and 12J/cm2 [12–14]; second, it took about 60
minutes to irradiate 10J/cm2 of UVA1 using our equipment,
and therefore the irradiation over 10J/cm2 seemed quite
stressfulformice.Underthedeepanesthesia,allofmicewere
shaved at the upper dorsal skin twice a week, because the
spontaneous LE-like skin lesions would appear on this site at
older ages. Mice were irradiated UVA1 (5J/cm2 or 10J/cm2)
ﬁve times a week for 4 months. The nonirradiated mice were
left untreated after shaving. LE-like skin lesions of mice were
macroscopically evaluated. The mortality was also estimated
during experimental period.
2.4. Proteinuria. At 4 months after the ﬁrst UVA1 irradia-
tion,urinesampleswerecollected,andtheirproteincontents
were quantitatively tested in order to monitor the onset
and degree of renal disease using ALBUSTIX urine test
paper(Miles-SankyoCo.,Ltd,Tokyo,Japan).Proteinuriawas
Table 1: Eﬀects of UVA1 irradiation on the development of
spontaneous LE-like skin lesions in MRL/lpr mice.
Mice Skin lesions Total
− ++ +
Nonirradiated 12 4 (18.2) 6 (27.3) 22
UVA1 31 5 (13.9) 0 36#
5J/cm2 16 2 (11.1) 0 18$
10J/cm2 15 3 (16.7) 0 18
(++) : mice with macroscopic skin lesions;
(+): mice with only histological change in the skin;
(-): mice without skin lesions;
Regarding the frequency of spontaneous LE-like skin lesions in MRL/lpr
mice, there was a signiﬁcant diﬀerence between the non-irradiated and all
UVA1-irradiated groups (#, p<0.05), and between the non-irradiated
and UVA1-irradiated (only 5J/cm2)g r o u p( $ ,p<0.05). UVA1 irradiation
signiﬁcantly protected mice against the development of LE-like skin lesions.
evaluated as negative (0–30mg/dL), 1 + (30–100mg/dL),
2 + (100–300mg/dL), and 3 + (300–1000mg/dL).
2.5. Measurements of Antinuclear Antibody (ANA) in Sera.
Serum samples, collected at 4 months after the ﬁrst irradi-
ation, were subjected to ANA analysis by a commercial kit
(Fluoro HEPANA test, MBL Co., Ltd, Nagoya, Japan), as
described previously [21].
2.6. Light Microscopic Observation of the Skin. At 4 months
after the ﬁrst irradiation, mice were euthanized by the
cervical dislocation, and skin specimens were taken from the
upper back regions of all mice. The specimens were ﬁxed
in 4% formaldehyde buﬀered with PBS (pH 7.2), embedded
in paraﬃn, and stained with hematoxylin and eosin (HE).
Toluidinebluestainingwasalsoperformedtoassesstheinﬁl-
tration of mast cells. For the evaluation of dermal inﬁltrating
mast cells, 5 microscopic ﬁelds were randomly selected, and
the number of mast cells was counted. The degree of mast
cells inﬁltration was expressed as the average number of the
mast cells in the 5 microscopic ﬁelds (magniﬁcation, ×100).
All measurements were performed without prior knowledge
of the experimental procedures.
2.7. Light Microscopic Observation of the Kidney. Kidney
specimens taken from all MRL/lpr mice were subjected to
HE and periodic acid-Schiﬀ (PAS) staining. Then, the degree
of glomerulonephritis was evaluated according to previously
described methods [22] with a slight modiﬁcation. All
measurements were performed without prior knowledge of
the experimental procedures.
2.8. Immunohistochemical Study. Skin specimens were
frozen immediately in Tissue-Tek O.C.T. Compound
(Sakura Finetechnical Co., Ltd, Tokyo, Japan) to be stored
at −80◦C until the use. Cryosections (6μm thick) were
prepared using Cryostat CM1900 (Leica Microsystems,
Heidelberg, Germany), and the sections were reacted with
anti-H1R pAbs, anti-H2R pAbs, or anti-H3R pAbs. After
the incubation of biotinylated secondary Abs, immuneClinical and Developmental Immunology 3
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Figure 1: Macroscopic and histopathological ﬁndings of the skin representative of MRL/lpr mice. (a), (d): nonlesional skin of nonirradiated
mice.(b),(e):spontaneousLE-likeskinlesionofnonirradiatedmice.(c),(f):nonlesionalskinofUVA1-irradiated(10J/cm2)mice.Asshown
in Table 1, some of the nonirradiated MRL/lpr mice developed LE-like skin lesions with alopecia and scab formation (b). In the spontaneous
LE-likeskinlesions,histopathologically,acanthosiswithhyperkeratosis,liquefaction,andmononuclearcellinﬁltrationsintothedermiswere
noted (e). On the other hand, none of the UVA1-irradiated mice showed LE-like skin lesions (c). Most of the nonlesional mice did not show
any histological changes (d), (f). (d), (e), (f): HE stain, original magniﬁcation, ×60.
complexes were visualized using VECTASTAIN Elite
ABC Kits (Vector Laboratories, Burlingame, Calif, USA),
according to the manufacturer’s instructions.
2.9. Immunoﬂuorescence Study. To investigate the immu-
noglobulin deposits in the skin, cryosections were immunos-
tained with Alexa Fluor 488-conjugated antimouse IgG
(Invitrogen,Eugene,Ore,USA).Inanotherseries,toevaluate
the IL-10 production by mast cells, cryosections were
double-immunostained with rat antimouse IL-10 mAb and
avidin-Texas Red (BD Biosciences, San Jose, Calif, USA).
AftertheincubationwithAlexaFlour488-conjugatedantirat
IgG (Invitrogen) as secondary Ab, the stained sections were
observed with Radiance 2100 Confocal Microscope System
(Bio-Rad Laboratories, Hercules, Calif, USA).
2.10. Terminal Deoxynucleotidyl Transferase- (TdT-) Medi-
ateddUTPNickEndLabeling(TUNEL). Apoptotic cellswere
detected by the use of In Situ Cell Death Detection Kit, Flu-
orescein (Roche Diagnostics KK, Tokyo, Japan), followed by
nuclear labeling with Hoechst 33342 (Invitrogen). Moreover,
some sections were incubated with avidin-Texas Red prior to
in situ TUNEL.
2.11. Reverse Transcription-Polymerase Chain Reaction (RT-
PCR) Analysis. T h el e v e l so fm R N Ae x p r e s s i o no fT N F -
α,I F N - γ, IL-4, IL-10, TGF-β, H1R, H2R, and H3R were
determined by RT-PCR analyses, as described previously
[19–21]. Brieﬂy, the total RNAs were extracted from dorsal
skin specimens with Sepazol-RNA I (Nacalai Tesque, Inc.,
Kyoto, Japan) and reverse transcribed using a SuperScript III
First-Strand cDNA Synthesis System (Invitrogen) according
to the manufacturer’s protocol. The PCR was performed
using Ex Taq (TAKARA BIO INC., Otsu, Japan) and Applied
Biosystems2720 ThermalCycler (AppliedBiosystems,Foster
City, Calif, USA). The PCR products were electrophoresed
on a 2% agarose gel and visualized by ethidium bromide
staining.
2.12. Statistical Analysis. For comparisons on the frequency
of LE-like skin lesions and the mortality, Fisher’s exact
probability test was used. For comparisons on the mast cells
recruitment and proteinuria, Student’s t-test was employed.
P-values less than .05 were regarded as statistically signiﬁ-
cant.
3. Results and Discussion
3.1. Protective Eﬀects of the UVA1 Irradiation on the Devel-
opment of LE-Like Skin Lesions in MRL/lpr Mice. At the end
point of the experiments, 6 (27.3%) out of 22 MRL/lpr
mice without UVA1 irradiation apparently developed the
macroscopic spontaneous LE-like skin lesions with hair
loss and scab formation on their upper back region4 Clinical and Developmental Immunology
(Table 1, Figure 1(b)). On the other hand, macroscopic skin
lesions were never seen in all UVA1-irradiated (5J/cm2
or 10J/cm2)m i c e( Table 1, Figure 1(c)). As reported pre-
viously [6–8], nonirradiated MRL/lpr mice with macro-
scopic skin lesions showed characteristic histopathological
alterations such as acanthosis with hyperkeratosis, lique-
faction, mononuclear cell inﬁltration into the dermis, and
slight extravasation of erythrocytes in the upper dermis
(Figure 1(e)). Moreover, even 4 nonirradiated mice without
macroscopicskinlesionsshowedmoderatehistopathological
changes mentioned above, while 5 mice in the UVA1
irradiated groups (5J/cm2:2m i c ea n d1 0 J / c m 2:3m i c e )
showed only LE-like histopathological changes. With respect
to the development of LE-like skin lesions, there was a
signiﬁcant diﬀerence between the nonirradiated and all
UVA1-irradiated groups, and between the nonirradiated
and UVA1-irradiated (only 5J/cm2)g r o u p s( Table 1, P<
.05). These observations implied that UVA1 irradiation
signiﬁcantly protected mice against the development of
spontaneous LE-like skin lesions.
3.2. Eﬀects of UVA1 Irradiation on the Mortality, Renal
Disease,andSerumANALevels. Toassessthesystemiceﬀects
of UVA1 irradiation on MRL/lpr mice, we evaluated the
mortality, the development of renal disease, and serum
ANA levels. The mortality of UVA1-irradiated MRL/lpr
mice, especially the 10J/cm2 irradiated group, tended to be
lower than that of the nonirradiated mice, without statistical
signiﬁcance (Table 2). MRL/lpr mice almost always showed
renal disease as evidenced by proteinuria, which was similar
to the human lupus nephritis with SLE. UVA1 irradiation
had no inﬂuence on proteinuria (Figure 2). Furthermore,
there was no signiﬁcant diﬀerence in renal histopathological
alterations among these three groups (data not shown).
Similarly, there was no signiﬁcant diﬀerence in the serum
ANA levels and immunoglobulin deposits in skin among
three groups (data not shown). These data suggested that, in
our experimental procedures, the eﬀects of UVA1 irradiation
on systemic symptoms of MRL/lpr mice were not signiﬁcant.
In comparison, some studies on human SLE patients have
reported that UVA1 therapy improved the systemic symp-
toms and parameters [12–15]. Considering the tendency of
improving mortality by UVA1 irradiation, further studies
of other parameters reﬂecting systemic immune functions
might show some systemic eﬀects of UVA1 in our system.
3.3. Eﬀects of UVA1 Irradiation on Dermal Inﬁltration of
Mast Cells. In consistent with the previous study [19], we
could detect massive inﬁltration of mast cells in the LE-like
skin lesions of MRL/lpr mice, compared with nonlesional
skins in both nonirradiated and UVA1-irradiated mice.
(Figures 3(b), 4). Furthermore, in nonlesional skins, mast
cell recruitment was more evident in UVA1-irradiated mice
than in nonirradiated ones (Figures 3(a), 3(c), 4). These
observations implied that mast cells might play a role in
the protective eﬀects of UVA1 irradiation as well as in the
development of spontaneous LE-like skin lesions. Recently,
it has been reported that mast cells have both positive and
Table 2: Mortality of MRL/lpr mice during experimental period.
Regarding the mortality of MRL/lpr mice during the experimental
period, UVA1 irradiation tended to decrease the mortality of mice,
but not signiﬁcantly.
Mice Total number Number of dead mice
(%)
Nonirradiated 22 5 (22.7)
UVA1 36 7 (19.4)
5J/cm2 18 4 (22.2)
10J/cm2 18 3 (16.7)
There were no signiﬁcant diﬀerences among three groups.
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Figure 2: Degree of proteinuria in MRL/lpr mice of the three
groups. There were no signiﬁcant diﬀerences among the three
groups.UVA1irradiationhadnoeﬀectonthedegreeofproteinuria.
The data represent means ± 1S D .
negative regulatory functions for immunity [23]. Mast cells
produce IL-10, eventually playing a negative role in the
immunomodulatory mechanisms. Actually, UVB irradiation
can induce IL-10 production in mast cells [24]. When we
examined the IL-10 localization in the skin samples by
immunoﬂuorescence analyses, IL-10-positive signals could
be detected in the cytoplasm of mast cells at the LE-like skin
lesions of nonirradiated mice (Figure 5(c), indicated with
arrows). Unexpectedly, mast cells recruited on the skin of
UVA1-irradiated mice never showed IL-10-positive signals
(Figure 5(f)). Thus, these observations implied at least that
UVA1 irradiation could not induce IL-10 production in
dermal mast cells in the present study.
3.4. Eﬀects of UVA1 Irradiation on the mRNA Expression of
Cytokines and the Immunochemical Examination and mRNA
Expression of Histamine Receptors. Several lines of accu-
mulating evidence demonstrated that histamine, a majorClinical and Developmental Immunology 5
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Figure 3: Dermal inﬁltration of mast cells in the lesional and nonlesional skin representative MRL/lpr mice. (a): nonlesional skin of non-
irradiated mice. (b): spontaneous LE-like skin lesion of nonirradiated mice. (c): nonlesional skin of UVA1-irradiated (10J/cm2)m i c e .I n
the LE-like skin lesions, the most remarkable inﬁltration of mast cells into dermis was detected (b). There was more number of mast cells
inﬁltrating into the dermis of the UVA1-irradiated (10J/cm2) mice (c), as compared to the nonirradiated mice (a). Toluidine blue stain,
original magniﬁcation, ×100.
inﬂammatory mediator mainly derived from mast cells, was
closely related with the development of LE-like skin lesions
of MRL/lpr mice through HRs [19, 25]. Tachibana et al.
suggested that the impairment of histamine metabolism
in MRL/lpr mice would contribute to the development
of LE-like skin lesions [25]. Actually, the gene expression
of H2R was signiﬁcantly enhanced in the LE-like skin
lesions of MRL/lpr mice, and H2R-expressing mononuclear
cells could be observed immunohistochemically [19]. The
diverse biological eﬀects of histamine are mediated through
four diﬀerent histamine receptors, H1R, H2R, H3R, and
H4R [26, 27]. We also examined the expression of the
histamine receptors in both the LE-like skin lesion and non-
lesional skins of nonirradiated and UVA1-irradiated mice by
immunohistochemical and RT-PCR analyses. Similar to our
previous results [19], some inﬁltrating mononuclear cells
expressed H2R in the LE-like skin lesions, and the expression
of H2R mRNA was signiﬁcantly up-regulated (data not
shown). However, in nonlesional skins of MRL/lpr mice,
there was no signiﬁcant change in H2R mRNA expression
between the nonirradiated and UVA1-irradiated mice.
In addition, we analyzed the mRNA expressions of TNF-
α,I F N - γ, IL-4, IL-10, and TGF-β. In the LE-like skin lesion,
we could observe more remarkable mRNA expressions of
TNF-α, IL-10, and TGF-β compared with nonlesional skin
ofnonirradiatedmice,asreportedinthepreviousstudy[20].
However, in the nonlesional skins, there were no signiﬁcant
changes between the nonirradiated and UVA1-irradiated
mice (data not shown). Brieﬂy, within our investigations, we
could not detect any signiﬁcant changes associated with the
protective eﬀects of UVA1 irradiation, regarding cytokines
and HRs.
3.5. Induction of Apoptosis of Dermal Cells with UVA1 Irradi-
ation. The apoptosis of inﬁltrating cells has been recognized
as one of the main mechanisms responsible for UVA1
treatment [16, 17, 28]. In the present study, TUNEL-positive
0
20
40
60
80
D
e
n
s
i
t
y
/
ﬁ
e
l
d
Non-lesional skin
of non-irradiated
mice
Lesional skin of
non-irradiated
mice
Non-lesional skin of
UVA1-irradiated
mice
##: Statistically signiﬁcant, P<. 01
#: Statistically signiﬁcant, P<. 05
#
##
##
Figure 4: Density of dermal inﬁltrating mast cells in the skin
of MRL/lpr mice. In the LE-like skin lesions of MRL/lpr mice,
the density of dermal inﬁltrating mast cells was the highest as
compared with the nonlesional skin of the other mice (P<. 01).
Furthermore, in the nonlesional skins, there was a signiﬁcant
diﬀerence between UVA1-irradiated (10J/cm2) and nonirradiated
mice (P<. 05). There was no signiﬁcant diﬀerence between UVA1
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Figure 5: Analysis of the production of IL-10 by mast cells in MRL/lpr mice. (a), (b), (c): spontaneous LE-like skin lesion of nonirradiated
mice. (d), (e), (f): nonlesional skin of UVA1-irradiated (10J/cm2) mice. Mast cells are labeled with avidin-Texas Red in red, while IL-10
is immunostained with anti-IL10 mAb and Alexa Fluor 488-conjugated secondary Ab in green. In the LE-like skin lesions, some double
immunopositive IL-10-producing mast cells were seen (yellow in (c), indicated by arrows). In contrast, in the nonlesional skin of UVA1-
irradiated (10J/cm2) mice, such cells were not detected (f). (a), (d): immunostain for IL-10, (b), (e): immunostain for mast cells, (c), (f):
merged images, original magniﬁcation, ×200.
cells were most remarkably seen in the dermis of the UVA1-
irradiated mice among the three groups (Figure 6(i)). On the
contrary, in the dermis of the nonirradiated mice without
skin lesion, TUNEL-positive cells were scarcely detectable
(Figure 6(c)). Although TUNEL-positive cells were seen
diﬀusely in the epidermis of the nonirradiated mice with
skin lesions, there were only a few TUNEL-positive cells
in the dermis (Figure 6(f)). Next, we determined the types
of cells showing TUNEL positive in the UVA1-irradiated
skins with confocal microscopy. We could conﬁrm that
some of TUNEL-positive cells were mast cells (Figures
7(a), 7(b), indicated with arrows). The apoptosis of dermal
mast cells might be closely associated with the reduction
of the development of LE-like skin lesions in the UVA1-
irradiated group. Thus, UVA1 irradiation might induce the
apoptosisofpathogenicmastcells,eventuallyattenuatingthe
development of spontaneous LE-like skin lesions of MRL/lpr
mice.
Our study demonstrated that mast cells might play
a role in the development of spontaneous LE-like skin
lesions of MRL/lpr mice. Although we also speculated the
possibility that UVA1 irradiation induced such mast cells
as aggressively inhibited the development of LE-like skin
lesions, for example, through the production of IL-10, we
could not conﬁrm such mast cells in the skin of UVA1-
irradiated mice. Thus, this implied that UVA1 irradiation
might induce the apoptosis of dermal pathogenic mast cells.
In consistent with our results, apoptosis of proliferating mast
cells was reported to be induced by UV in vitro, while resting
skin mast cells were resistant to UV light-induced apoptosis
[29]. However, as shown in Figure 7, UVA1 irradiation also
induced the apoptosis of other types of dermal cells, except
mast cells. Characterization of these apoptotic cells in the
dermis of UVA1-irradiated mice still remained unclear, and
we need further investigations, because several recent lines
reported the new insights on autoimmunity in MRL/lpr
mice through the impaired regulation of Langerhans cells
[30] or regulatory T cells [31, 32]. Besides mast cells, these
various immunocytes are speculated to be involved in the
development of spontaneous LE-like skin lesions of MRL/lpr
mice, and also the protective eﬀects on them by UVA1
irradiation. In this context, the apoptosis of mast cells by
UVA1 irradiation should be considered to contribute, but
only in part, to the eﬀects of UVA1.Clinical and Developmental Immunology 7
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Figure 6: TUNEL assay for the analysis of apoptotic cells in the skin of MRL/lpr mice. (a), (b), (c): nonlesional skin of nonirradiated
mice. (d), (e), (f): spontaneous LE-like skin lesion of nonirradiated mice. (g), (h), (i): nonlesional skin of UVA1-irradiated (10J/cm2)m i c e .
Positive cells for TUNEL assay are shown in green, whereas the nuclei are labeled with Hoechst 33342 in blue. In the nonlesional skin of
the UVA1-irradiated (10J/cm2) mice, TUNEL-positive cells were scattered in the dermis (g), (i). However, TUNEL-positive cells were rarely
seen in the dermis of the nonlesional skin of the nonirradiated mice (a), (c). In the LE-like skin lesions, TUNEL-positive cells were diﬀusely
detected in the hypertrophic epidermis, whereas in the dermis TUNEL-positive cells were hardly seen (d), (f). (a), (d), (g): TUNEL assay,
(b), (e), (h): nuclear staining, (c), (f), (i): merged images of TUNEL assay and nuclear staining images, original magniﬁcation, ×200).
InhumanLE,therehavebeenonlyfewreportsinvestigat-
ing mast cells in the skin lesions [33]. Studies on 7 Japanese
cases with chronic cutaneous LE revealed a 1.5-fold increase
ininﬁltrating mastcellscomparedwiththecontrolskin [34].
Although evidence is lacking, mast cells are considered good
candidates to mediate the tissue damage with autoantibodies
and immune complexes in SLE [35].
4. Conclusions
In the present study, we demonstrated that UVA1 irradiation
prevented the spontaneous development of macroscopic
LE-like skin lesions of MRL/lpr mice. On the contrary,
UVA1 irradiation did not have harmful systemic eﬀects. As
one of the mechanisms for the protective eﬀects of UVA18 Clinical and Developmental Immunology
(a) (b)
Figure 7: TUNEL-positive cells and mast cells in the UVA1-irradiated skin of MRL/lpr mice. Positive cells for TUNEL assay are shown in
green,whereasmastcellsarelabeledwithavidin-TexasRedtobeshowninred,andmergedimagesareshown.IntheskinofUVA1-irradiated
(10J/cm2)mice,somedoubleimmunopositiveapoptoticcells(yellow,indicatedbyarrows)wereseen.(a):originalmagniﬁcation, ×200,(b):
magniﬁed image of the indicated region of (a).
irradiation, we could suggest the induction of apoptosis of
dermal pathogenic mast cells. These observations supported
the possibility that UVA1 phototherapy would be one of the
more rational treatments for skin lesions of SLE patients.
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